Matthew McNeil

Matthew McNeil

University of Otago

H-index: 17

Oceania-New Zealand

About Matthew McNeil

Matthew McNeil, With an exceptional h-index of 17 and a recent h-index of 14 (since 2020), a distinguished researcher at University of Otago, specializes in the field of Microbiology, Biochemistry, Bacterial Genetics.

His recent articles reflect a diverse array of research interests and contributions to the field:

A dual-targeting succinate dehydrogenase and F1Fo-ATP synthase inhibitor rapidly sterilizes replicating and non-replicating Mycobacterium tuberculosis

The evolution of antibiotic resistance is associated with collateral drug phenotypes in Mycobacterium tuberculosis

KatG inactivation generates vulnerabilities in isoniazid resistant strains of Mycobacterium tuberculosis

Characterizing in vivo loss of virulence of an HN878 Mycobacterium tuberculosis isolate from a genetic duplication event

Novel chemical entities inhibiting Mycobacterium tuberculosis growth identified by phenotypic high-throughput screening

Impaired succinate oxidation prevents growth and influences drug susceptibility in Mycobacterium tuberculosis

Uncovering interactions between mycobacterial respiratory complexes to target drug-resistant Mycobacterium tuberculosis

Correction for Shelton et al.,“Deletion of Rv2571c Confers Resistance to Arylamide Compounds in Mycobacterium tuberculosis”

Matthew McNeil Information

University

Position

Department of Microbiology

Citations(all)

891

Citations(since 2020)

621

Cited By

475

hIndex(all)

17

hIndex(since 2020)

14

i10Index(all)

23

i10Index(since 2020)

19

Email

University Profile Page

Google Scholar

Matthew McNeil Skills & Research Interests

Microbiology

Biochemistry

Bacterial Genetics

Top articles of Matthew McNeil

A dual-targeting succinate dehydrogenase and F1Fo-ATP synthase inhibitor rapidly sterilizes replicating and non-replicating Mycobacterium tuberculosis

Cell Chemical Biology

2023/12/26

The evolution of antibiotic resistance is associated with collateral drug phenotypes in Mycobacterium tuberculosis

Nature Communications

2023/3/18

KatG inactivation generates vulnerabilities in isoniazid resistant strains of Mycobacterium tuberculosis

bioRxiv

2023

Characterizing in vivo loss of virulence of an HN878 Mycobacterium tuberculosis isolate from a genetic duplication event

Tuberculosis

2022/12/1

Novel chemical entities inhibiting Mycobacterium tuberculosis growth identified by phenotypic high-throughput screening

Scientific Reports

2022/9/1

Matthew Mcneil
Matthew Mcneil

H-Index: 11

Michael Curtin
Michael Curtin

H-Index: 14

Impaired succinate oxidation prevents growth and influences drug susceptibility in Mycobacterium tuberculosis

Mbio

2022/8/30

Uncovering interactions between mycobacterial respiratory complexes to target drug-resistant Mycobacterium tuberculosis

2022/8/24

Correction for Shelton et al.,“Deletion of Rv2571c Confers Resistance to Arylamide Compounds in Mycobacterium tuberculosis”

Antimicrobial Agents and Chemotherapy

2022/8/16

Deciphering functional redundancy and energetics of malate oxidation in mycobacteria

Journal of Biological Chemistry

2022/5/1

Triazolopyrimidines target aerobic respiration in Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy

2022/4/19

Matthew Mcneil
Matthew Mcneil

H-Index: 11

Utilization of CRISPR interference to investigate the contribution of genes to pathogenesis in a macrophage model of Mycobacterium tuberculosis infection

Journal of Antimicrobial Chemotherapy

2022/3/2

An amiloride derivative is active against the F1Fo-ATP synthase and cytochrome bd oxidase of Mycobacterium tuberculosis

Communications Biology

2022/2/24

Multiplexed transcriptional repression identifies a network of bactericidal interactions between mycobacterial respiratory complexes

Iscience

2022/1/21

CRISPR interference identifies vulnerable cellular pathways with bactericidal phenotypes in Mycobacterium tuberculosis

Molecular microbiology

2021/10

Novel Trifluoromethyl Pyrimidinone Compounds With Activity Against Mycobacterium tuberculosis

Frontiers in Chemistry

2021/4/29

Multiple mutations in Mycobacterium tuberculosis MmpL3 increase resistance to MmpL3 inhibitors

MSphere

2020/10/28

MmpL3 inhibitors as antituberculosis drugs

2020/8/15

Matthew Mcneil
Matthew Mcneil

H-Index: 11

Transcriptional Inhibition of the F1F0-Type ATP Synthase Has Bactericidal Consequences on the Viability of Mycobacteria

Antimicrobial agents and chemotherapy

2020/7/22

Two for the price of one: Attacking the energetic-metabolic hub of mycobacteria to produce new chemotherapeutic agents

2020/5/1

See List of Professors in Matthew McNeil University(University of Otago)